Potential effects of postmenopausal labial agglutination on the urinary system

Cheau Williams; Jermaine Robinson; Samantha Leggio

doi:10.1016/j.eucr.2021.101565

Potential effects of postmenopausal labial agglutination on the urinary system

Urol Case Rep. 2021 Jan 6:36:101565. doi: 10.1016/j.eucr.2021.101565. eCollection 2021 May.

Authors

Cheau Williams^{1

2

3

4}, Jermaine Robinson³, Samantha Leggio⁴

Affiliations

¹ Colquitt Regional Medical Center, Philadelphia College of Osteopathic Medicine, Moultrie, GA, USA.
² Medical College of Georgia, USA.
³ 2nd Year Resident at Colquitt Regional Medical Center, Georgia South Family Medicine Residency, Moultrie, GA, USA.
⁴ Philadelphia College of Osteopathic Medicine, USA.

Abstract

Labial agglutination (LA) can affect prepubertal or postmenopausal women. LA commonly affects prepubertal girls, but the rate at which LA affects postmenopausal women is unknown, with only a few documented case reports. Symptoms of LA include vulvovaginal pain, dysuria, dyspareunia, and urinary incontinence/urinary symptoms. First-line treatment includes low dose estrogen cream and high dose topical steroid cream. If the creams fail, surgical lysis can be performed. The commonality between these age groups is chronic inflammation and low estrogen. It is important to keep in mind, especially in postmenopausal women, that LA can lead to urinary symptom side effects.

Keywords: LA, labial agglutination; LMA, labial minora agglutination; LS, lichen sclerosus; Labial agglutination/labial adhesions labial agglutination lysis urinary incontinence pseudo-incontinence lichen sclerosus prepubertal postmenopausal; Post-op, post-operation; SCC, squamous cell carcinoma; UTI, urinary tract infection.

Publication types

Case Reports